000			02177 a2200661 4500
005			20250516235933.0
264		0	_c20150406
008			201504s 0 0 eng d
022			_a1476-5551
024	7		_a10.1038/leu.2014.300 _2doi
040			_aNLM _beng _cNLM
100	1		_aSuzuki, R
245	0	0	_aAnti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma. _h[electronic resource]
260			_bLeukemia _cFeb 2015
300			_a510-4 p. _bdigital
500			_aPublication Type: Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aApoptosis
650	0	4	_aBenzamides _xadministration & dosage
650	0	4	_aBoronic Acids _xadministration & dosage
650	0	4	_aBortezomib
650	0	4	_aCell Line
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation
650	0	4	_aCell Survival
650	0	4	_aDrug Screening Assays, Antitumor
650	0	4	_aHSP90 Heat-Shock Proteins _xantagonists & inhibitors
650	0	4	_aHumans
650	0	4	_aMice
650	0	4	_aMice, SCID
650	0	4	_aMonomeric GTP-Binding Proteins _xmetabolism
650	0	4	_aMultiple Myeloma _xdrug therapy
650	0	4	_aMutation
650	0	4	_aNeoplasm Transplantation
650	0	4	_aPyrazines _xadministration & dosage
650	0	4	_aPyrazoles _xadministration & dosage
650	0	4	_aRetinal Pigment Epithelium _xcytology
700	1		_aHideshima, T
700	1		_aMimura, N
700	1		_aMinami, J
700	1		_aOhguchi, H
700	1		_aKikuchi, S
700	1		_aYoshida, Y
700	1		_aGorgun, G
700	1		_aCirstea, D
700	1		_aCottini, F
700	1		_aJakubikova, J
700	1		_aTai, Y-T
700	1		_aChauhan, D
700	1		_aRichardson, P G
700	1		_aMunshi, N C
700	1		_aUtsugi, T
700	1		_aAnderson, K C
773	0		_tLeukemia _gvol. 29 _gno. 2 _gp. 510-4
856	4	0	_uhttps://doi.org/10.1038/leu.2014.300 _zAvailable from publisher's website
999			_c24270303 _d24270303